Cargando…
Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
BACKGROUND: Cholangiocellular cancers account for about 10-15% of primary liver cancers. Prognosis is poor, with expected survival of less than 5% at five-year. CASE PRESENTATION: The case described shows remission of a disseminated cholangiocellular carcinoma (focal changes in liver, metastases to...
Autores principales: | Slupski, Maciej W, Szczylik, Cezary, Jasinski, Milosz K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839091/ https://www.ncbi.nlm.nih.gov/pubmed/17376238 http://dx.doi.org/10.1186/1477-7819-5-36 |
Ejemplares similares
-
Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer
por: Zhang, Caihua, et al.
Publicado: (2012) -
Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
por: Wentrup, Robert, et al.
Publicado: (2016) -
Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch
por: Ishii, Hiromichi, et al.
Publicado: (2012) -
Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer
por: Guardiola, Emmanuel, et al.
Publicado: (2009) -
Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy
por: Boutros, Cherif, et al.
Publicado: (2010)